Display options
Cite
Ouoba K, Lehmann H, Semde R, et al. Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie I: identification des risques. [Literature review on pharmacovigilance of medicines derived from traditional pharmacopoeias. Part I: risks identification]. Ann Pharm Fr. 2021;doi: 10.1016/j.pharma.2021.11.008.
Ouoba, K., Lehmann, H., Semde, R., & Pabst, J. Y. (2021). Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie I: identification des risques. [Literature review on pharmacovigilance of medicines derived from traditional pharmacopoeias. Part I: risks identification]. Annales pharmaceutiques francaises, . https://doi.org/10.1016/j.pharma.2021.11.008
Ouoba, Kampadilemba, et al. "Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie I: identification des risques." [Literature review on pharmacovigilance of medicines derived from traditional pharmacopoeias. Part I: risks identification]. Annales pharmaceutiques francaises vol. (2021). doi: https://doi.org/10.1016/j.pharma.2021.11.008
Ouoba K, Lehmann H, Semde R, Pabst JY. Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie I: identification des risques. [Literature review on pharmacovigilance of medicines derived from traditional pharmacopoeias. Part I: risks identification]. Ann Pharm Fr. 2021 Dec 13; doi: 10.1016/j.pharma.2021.11.008. Epub 2021 Dec 13. French. PMID: 34914891.
Copy Download .nbib Format: NLM
Share it on

Ann Pharm Fr. 2021 Dec 13; doi: 10.1016/j.pharma.2021.11.008. Epub 2021 Dec 13.

[Literature review on pharmacovigilance of medicines derived from traditional pharmacopoeias. Part I: risks identification].

Annales pharmaceutiques francaises

[Article in French]
Kampadilemba Ouoba, Hélène Lehmann, Rasmané Semde, Jean-Yves Pabst

Affiliations

  1. Laboratoire du Développement du Médicament (LADME), Centre de Formation, de Recherche et d'Expertises en sciences du Médicament (CEA-CFOREM), Ecole doctorale sciences et santé (ED2S), université Joseph KI-ZERBO, 03 BP 7021 Ouagadougou, Burkina Faso; EA 7307, Centre d'études internationales et européennes (CEIE), faculté de pharmacie, université de Strasbourg, 74, route du Rhin, 67400 Illkirch, France. Electronic address: [email protected].
  2. EA 4487, Centre de recherches en droit et perspectives du droit, faculté de pharmacie, université de Lille, rue du Professeur-Laguesse, BP 53, 59006 Lille, France.
  3. Laboratoire du Développement du Médicament (LADME), Centre de Formation, de Recherche et d'Expertises en sciences du Médicament (CEA-CFOREM), Ecole doctorale sciences et santé (ED2S), université Joseph KI-ZERBO, 03 BP 7021 Ouagadougou, Burkina Faso.
  4. EA 7307, Centre d'études internationales et européennes (CEIE), faculté de pharmacie, université de Strasbourg, 74, route du Rhin, 67400 Illkirch, France.

PMID: 34914891 DOI: 10.1016/j.pharma.2021.11.008

Abstract

Globally, the use of drugs from traditional pharmacopoeias is a major subject. The confidence of the populations in these drugs is linked to their presumption of safety and also to the fact that geographically and financially they are more accessible than synthetic drugs. In view of the high exposure of the world population to traditional medicines, they are subject to pharmacovigilance guaranteeing their safety in use. Thus, this review aims to take stock of the risks identified by the national pharmacovigilance systems. It is based on research referenced in PubMed, Embase, ScienceDirect and GoogleScholar. These studies indicate that the use of traditional drugs can involve risks including adverse effects, interactions with synthetic drugs, adulteration and contamination. The spontaneous notification system was the basis for their identification. Strengthening this system and making populations aware of these risks constitute the key levers for traditional medicines pharmacovigilance progress.

Copyright © 2021 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.

Keywords: pharmacovigilance; risks of use; spontaneous notification; traditional medicines; traditional pharmacopoeia

Publication Types